期刊
BRAIN RESEARCH
卷 1022, 期 1-2, 页码 164-172出版社
ELSEVIER
DOI: 10.1016/j.brainres.2004.07.026
关键词
1-methyl-4-phenyl-pyridinium; Parkinson's disease; Lewy body; dementia with Lewy bodies; pancreatic protein disulfide isomerase
资金
- NIA NIH HHS [P30 AG 13846, R37 AG 05894] Funding Source: Medline
Parkinson's disease (PD) is a slowly progressing neurodegenerative disorder with no clear etiology. Pathological hallmarks of the disease include the loss of dopaminergic neurons from the substantia nigra (SN) and the presence of Lewy bodies (LBs) (alpha-synuclein and ubiquitin-positive, eosinophilic, cytoplasmic inclusions) in many of the surviving neurons. Experimental modeling of PD neurodegeneration using the neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenyl-pyridinium (MPP+) has identified changes in gene expression of different endoplasmic reticulum (ER) stress proteins associated with MPTP- and PD-related neurodegeneration. We show that the protein disulfide isomerase (PDI) family member pancreatic protein disulfide isomerase (PDIp), previously considered exclusively expressed in pancreatic tissue, is uniquely upregulated among PDI family members within 24 h following exposure of retinoic acid (RA)-differentiated SH-SY5Y human neuroblastoma cells to either 1 mM MPP+ or 10 muM of the highly specific proteasome inhibitor lactacystin. RT-PCR confinns PDIp expression in brain of post-mortem human PD subjects and immunohistochemical studies demonstrate PDIp immumoreactivity in LBs. Collectively, these findings suggest that increased PDIp expression in dopaminergic (DA) neurons might contribute to LB formation and neurodegeneration, and that this increased PDIp expression may be the result of proteasome impairment. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据